Organovo Holdings Company
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
%20.jpg)
Founded Date:
2007
Industry:
PharmTech
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series E
Total Funding:
$117.4M
Headquarters:
San Diego, California, United States
Technology:
Others
Investors Number:
2
Employee Number:
51-100
Funding Status:
IPO